Case number 1:22-cv-00911
Takeda Pharmaceuticals U.S.A., Inc. et al v. Sun Pharmaceutical Industries Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 28, 2023 | 56 | [SEALED] ORDER Granting 55 Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 6/28/2023.*This order has been emailed to local counsel. (nms) (Entered: 06/28/2023) (0) |
| Jun 27, 2023 | 55 | [SEALED] STIPULATION and [Proposed] Order to Extend Time - by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) (Entered: 06/27/2023) (0) |
| Jun 23, 2023 | 54 | STIPULATION and Proposed Order for Extension of Time to serve Answering Claim Construction Brief and Responses to Plaintiffs' First Set of Requests for Production and First Set of Interrogatories to Defendants by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) (Entered: 06/23/2023) (2) |
| Jun 15, 2023 | 53 | STIPULATION and Proposed Order for extension of time to serve Answering Claim Construction Brief to June 23, 2023 - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) Modified on 6/16/2023 (nms). (Entered: 06/15/2023) (2) |
| Jun 8, 2023 | 52 | STIPULATION and Proposed Order to Extend Time Regarding Claim Construction Deadlines, by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) Modified on 6/8/2023 (nms). (Entered: 06/08/2023) (2) |
| Jun 5, 2023 | 51 | STIPULATION and Proposed Order to Extend Time - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) Modified on 6/5/2023 (nms). (Entered: 06/05/2023) (2) |
| May 12, 2023 | 50 | NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (Nos. 1-5) - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Jacobs, Karen) (Entered: 05/12/2023) (3) |
| May 11, 2023 | 49 | SO ORDERED Granting 48 STIPULATION and Proposed Order to Extend Time regarding claim construction deadlines (*Reset Deadlines: Joint Claim Construction Brief due by 7/13/2023). Signed by Judge Richard G. Andrews on 5/11/2023. (nms) (Entered: 05/11/2023) (2) |
| May 11, 2023 | 48 | STIPULATION and Proposed Order to Extend Time regarding claim construction deadlines - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) Modified on 5/11/2023 (nms). (Entered: 05/11/2023) (2) |
| May 10, 2023 | 47 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-59) - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Fahnestock, Derek) (Entered: 05/10/2023) (3) |
| Apr 24, 2023 | 46 | NOTICE OF SERVICE of Takeda's Opening Claim Construction Brief filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Fahnestock, Derek) (Entered: 04/24/2023) (3) |
| Apr 10, 2023 | 45 | APPENDIX re 44 Joint Claim Construction Chart, by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibits 1-25)(Fahnestock, Derek) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (Exs. 1-25) (30) |
| Apr 10, 2023 | 45 | APPENDIX re 44 Joint Claim Construction Chart, by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibits 1-25)(Fahnestock, Derek) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (Main Document) (4) |
| Apr 10, 2023 | 44 | Joint Claim Construction Chart, by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (7) |
| Mar 31, 2023 | 43 | NOTICE OF SERVICE of Plaintiffs' Proposed Claim Construction of the Terms Identified to be Construed - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Fahnestock, Derek) (Entered: 03/31/2023) (3) |
| Mar 13, 2023 | 42 | STIPULATION and Proposed Order to Extend Time - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) Modified on 3/13/2023 (nms). (Entered: 03/13/2023) (2) |
| Mar 8, 2023 | 41 | NOTICE OF SERVICE of Plaintiffs' Proposed Terms/Phrases for Claim Construction filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Fahnestock, Derek) (Entered: 03/08/2023) (3) |
| Mar 8, 2023 | 40 | NOTICE OF SERVICE of Defendants, Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.'s Proposed Terms for Claim Construction filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 03/08/2023) (2) |
| Feb 28, 2023 | 39 | STIPULATION and Proposed Order to Extend Time for (1) the provision of lists of term(s)/phrase(s) the parties believe need construction; and (2) the provision of proposed claim construction of identified term(s)/phrase(s) to March 8, 2023 and March 15, 2023 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) Modified on 2/28/2023 (nms). (Entered: 02/28/2023) (2) |
| Feb 27, 2023 | 38 | SO ORDERED Granting 37 Protective Order. Signed by Judge Richard G. Andrews on 2/27/2023. (nms) (Entered: 02/27/2023) (21) |
| Feb 27, 2023 | 37 | PROPOSED Protective Order, by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) Modified on 2/27/2023 (nms). (Entered: 02/27/2023) (21) |
| Feb 17, 2023 | 36 | STIPULATION and Proposed Order to Extend Time to file proposed protective order to February 27, 2023 - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) Modified on 2/17/2023 (nms). (Entered: 02/17/2023) (2) |
| Feb 3, 2023 | 35 | STIPULATION and Proposed Order to Extend Time to file a proposed protective order to February 17, 2023 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) Modified on 2/3/2023 (nms). (Entered: 02/03/2023) (2) |
| Jan 19, 2023 | 34 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to February 3, 2023 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) (Entered: 01/19/2023) (2) |
| Jan 6, 2023 | 33 | NOTICE OF SERVICE of Plaintiffs' Paragraph 4(c) Initial Claim Chart - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Fahnestock, Derek) (Entered: 01/06/2023) (3) |
| Jan 6, 2023 | 32 | STIPULATION and Proposed Order to Extend Time to file a proposed protective order to January 20, 2023 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) Modified on 1/6/2023 (nms). (Entered: 01/06/2023) (2) |
| Dec 28, 2022 | 31 | STIPULATION TO EXTEND TIME (1) for Plaintiffs to provide their initial claim chart relating each accused product to the asserted claims each product allegedly infringes and (2) for Defendants to provide their initial invalidity contentions for each asserted claim, as well as the related allegedly invalidating references to January 6, 2023 and February 28, 2023, respectively - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) (Entered: 12/28/2022) (2) |
| Dec 20, 2022 | 30 | STIPULATION TO EXTEND TIME to File a Proposed Protective order to January 6, 2023 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Jacobs, Karen) (Entered: 12/20/2022) (2) |
| Dec 9, 2022 | 29 | STIPULATION TO EXTEND TIME (1) for Plaintiffs to provide their initial claim chart relating each accused product to the asserted claims each product allegedly infringes and (2) for Defendants to provide their initial invalidity contentions for each asserted claim, as well as the related allegedly invalidating references to December 29, 2022 and February 20, 2023, respectively - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) (Entered: 12/09/2022) (2) |
| Dec 6, 2022 | 26 | STIPULATION and Proposed Order to Extend Time - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) Modified on 12/6/2022 (nms). (Entered: 12/06/2022) (2) |
| Dec 6, 2022 | 27 | NOTICE OF SERVICE of Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc.'s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 12/06/2022) (2) |
| Dec 6, 2022 | 28 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Fahnestock, Derek) (Entered: 12/06/2022) (3) |
| Nov 22, 2022 | 25 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to December 6, 2022 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) (Entered: 11/22/2022) (2) |
| Nov 14, 2022 | 24 | STIPULATION and Proposed Order to Extend Time to file a proposed protective order to November 22, 2022 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) Modified on 11/14/2022 (nms). (Entered: 11/14/2022) (2) |
| Oct 31, 2022 | 23 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to November 14, 2022 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) (Entered: 10/31/2022) (2) |
| Oct 17, 2022 | 22 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to October 31, 2022 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Fahnestock, Derek) (Entered: 10/17/2022) (2) |
| Oct 7, 2022 | 21 | NOTICE OF SERVICE of Plaintiffs' Initial Identification of Accused Products and Asserted Patents - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Fahnestock, Derek) (Entered: 10/07/2022) (3) |
| Oct 3, 2022 | 20 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to October 17, 2022 - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Jacobs, Karen) (Entered: 10/03/2022) (2) |
| Sep 23, 2022 | 19 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Under Fed. R. Civ. P. 26(a)(1) - filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc..(Fahnestock, Derek) (Entered: 09/23/2022) (3) |
| Sep 23, 2022 | 18 | NOTICE OF SERVICE of Defendants, Sun Pharmaceutical Industries, Ltd. and Sun Pharmaceutical Industries, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) (Entered: 09/23/2022) (2) |
| Sep 2, 2022 | 15 | PROPOSED Scheduling Order, by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 9/2/2022 (nms). (Entered: 09/02/2022) (Letter to The Honorable Richard G. Andrews) (1) |
| Sep 2, 2022 | 17 | ORAL ORDER: The Rule 16(b) Conference scheduled for 9/7/2022, is CANCELED. Ordered by Judge Richard G. Andrews on 9/2/2022. (nms) (Entered: 09/02/2022) (0) |
| Sep 2, 2022 | 16 | SCHEDULING ORDER: Joinder of Parties due by 5/31/2023. Amended Pleadings due by 5/31/2023. Discovery due by 9/29/2023. Joint Claim Construction Brief due by 6/7/2023. A Markman Hearing is set for 8/22/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/10/2024, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 5/28/2024, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/2/2022. (nms) (Entered: 09/02/2022) (10) |
| Sep 2, 2022 | 15 | PROPOSED Scheduling Order, by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 9/2/2022 (nms). (Entered: 09/02/2022) (Main Document) (12) |
| Sep 1, 2022 | 14 | Letter to The Honorable Richard G. Andrews from Karen Jacobs regarding dial-in number for September 7, 2022 Rule 16 conference. (Jacobs, Karen) (Entered: 09/01/2022) (1) |
| Aug 4, 2022 | 12 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan - filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) |
| Aug 4, 2022 | 13 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 9/7/2022, at 9:00 AM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 8/4/2022. (nms) |
| Aug 4, 2022 | 11 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Production of Defendants' Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery and Pursuant to the Standing Order Regarding Hatch-Waxman Cases in Which Infringement is Alleged filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| Aug 4, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Timothy H. Kratz and Michael P. Hogan for Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Aug 4, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz and Michael P. Hogan, filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Ltd.. Signed by Judge Richard G. Andrews on 8/4/2022. (nms) |
| Aug 3, 2022 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Ltd. for Sun Pharmaceutical Industries, Inc. filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) |
| Aug 3, 2022 | 9 | Answer to Complaint (16) Docket Text: ANSWER to [1] Complaint, by Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| Jul 15, 2022 | 8 | Affidavit of Service (10) Docket Text: AFFIDAVIT of Service for Complaint and supporting papers served on Sun Pharmaceutical Industries Ltd. on July 13, 2022, filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (Jacobs, Karen) |
| Jul 13, 2022 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceutical Company Ltd.. Sun Pharmaceutical Industries, Inc. served on 7/13/2022, answer due 8/3/2022. (Jacobs, Karen) |
| Jul 13, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 7, 2022 | 1 | Complaint* (1) |
| Jul 7, 2022 | 6 | Summons Issued (4) Docket Text: Summons Issued as to Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (twk) |
| Jul 7, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliates Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc.. (twk) |
| Jul 7, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,846,100 B2; 9,173,857 B2. (twk) |
| Jul 7, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 25, 2022. Date of Expiration of Patent: U.S. Patent No. 8,846,100 expires on August 24, 2029 and U.S. Patent No. 9,173,857 expires on May 12, 2026. Thirty Month Stay Deadline: 11/25/2024. (twk) |
| Jul 7, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Jul 7, 2022 | 1 | Civil Cover Sheet (1) |
| Jul 7, 2022 | 1 | Exhibit A-B (68) |
| Jul 7, 2022 | 1 | Main Document (16) Docket Text: COMPLAINT filed against Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. ( Filing fee $ 402, receipt number ADEDC-3911516.) - filed by Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceutical Company Ltd.. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(twk) |
